Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12238917rdf:typepubmed:Citationlld:pubmed
pubmed-article:12238917lifeskim:mentionsumls-concept:C0030851lld:lifeskim
pubmed-article:12238917lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:12238917lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:12238917lifeskim:mentionsumls-concept:C1540171lld:lifeskim
pubmed-article:12238917lifeskim:mentionsumls-concept:C1709915lld:lifeskim
pubmed-article:12238917lifeskim:mentionsumls-concept:C0332256lld:lifeskim
pubmed-article:12238917lifeskim:mentionsumls-concept:C0456378lld:lifeskim
pubmed-article:12238917lifeskim:mentionsumls-concept:C1553478lld:lifeskim
pubmed-article:12238917pubmed:issue20lld:pubmed
pubmed-article:12238917pubmed:dateCreated2002-9-19lld:pubmed
pubmed-article:12238917pubmed:abstractTextReplacing Cys(5) by Pen (penicillamine, beta,beta-dimethylcysteine) in the cyclic C-terminal U-II octapeptide, U-II(4-11), we have obtained a potent urotensin II (U-II) receptor agonist. Conformational analysis of solution NMR data indicated that the putative biologically active conformation of U-II is stabilized by introduction of a Pen residue. To the best of our knowledge, this is the most potent U-II receptor agonist reported to date.lld:pubmed
pubmed-article:12238917pubmed:languageenglld:pubmed
pubmed-article:12238917pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12238917pubmed:citationSubsetIMlld:pubmed
pubmed-article:12238917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12238917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12238917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12238917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12238917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12238917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12238917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12238917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12238917pubmed:statusMEDLINElld:pubmed
pubmed-article:12238917pubmed:monthSeplld:pubmed
pubmed-article:12238917pubmed:issn0022-2623lld:pubmed
pubmed-article:12238917pubmed:authorpubmed-author:PatacchiniRic...lld:pubmed
pubmed-article:12238917pubmed:authorpubmed-author:CarotenutoAlf...lld:pubmed
pubmed-article:12238917pubmed:authorpubmed-author:MaggiCarlo...lld:pubmed
pubmed-article:12238917pubmed:authorpubmed-author:GriecoPaoloPlld:pubmed
pubmed-article:12238917pubmed:authorpubmed-author:NovellinoEtto...lld:pubmed
pubmed-article:12238917pubmed:authorpubmed-author:RoveroPaoloPlld:pubmed
pubmed-article:12238917pubmed:authorpubmed-author:CampigliaPiet...lld:pubmed
pubmed-article:12238917pubmed:authorpubmed-author:ZampelliEnric...lld:pubmed
pubmed-article:12238917pubmed:issnTypePrintlld:pubmed
pubmed-article:12238917pubmed:day26lld:pubmed
pubmed-article:12238917pubmed:volume45lld:pubmed
pubmed-article:12238917pubmed:ownerNLMlld:pubmed
pubmed-article:12238917pubmed:authorsCompleteYlld:pubmed
pubmed-article:12238917pubmed:pagination4391-4lld:pubmed
pubmed-article:12238917pubmed:dateRevised2006-7-7lld:pubmed
pubmed-article:12238917pubmed:meshHeadingpubmed-meshheading:12238917...lld:pubmed
pubmed-article:12238917pubmed:meshHeadingpubmed-meshheading:12238917...lld:pubmed
pubmed-article:12238917pubmed:meshHeadingpubmed-meshheading:12238917...lld:pubmed
pubmed-article:12238917pubmed:meshHeadingpubmed-meshheading:12238917...lld:pubmed
pubmed-article:12238917pubmed:meshHeadingpubmed-meshheading:12238917...lld:pubmed
pubmed-article:12238917pubmed:meshHeadingpubmed-meshheading:12238917...lld:pubmed
pubmed-article:12238917pubmed:meshHeadingpubmed-meshheading:12238917...lld:pubmed
pubmed-article:12238917pubmed:meshHeadingpubmed-meshheading:12238917...lld:pubmed
pubmed-article:12238917pubmed:meshHeadingpubmed-meshheading:12238917...lld:pubmed
pubmed-article:12238917pubmed:meshHeadingpubmed-meshheading:12238917...lld:pubmed
pubmed-article:12238917pubmed:meshHeadingpubmed-meshheading:12238917...lld:pubmed
pubmed-article:12238917pubmed:meshHeadingpubmed-meshheading:12238917...lld:pubmed
pubmed-article:12238917pubmed:meshHeadingpubmed-meshheading:12238917...lld:pubmed
pubmed-article:12238917pubmed:meshHeadingpubmed-meshheading:12238917...lld:pubmed
pubmed-article:12238917pubmed:meshHeadingpubmed-meshheading:12238917...lld:pubmed
pubmed-article:12238917pubmed:meshHeadingpubmed-meshheading:12238917...lld:pubmed
pubmed-article:12238917pubmed:meshHeadingpubmed-meshheading:12238917...lld:pubmed
pubmed-article:12238917pubmed:year2002lld:pubmed
pubmed-article:12238917pubmed:articleTitleA new, potent urotensin II receptor peptide agonist containing a Pen residue at the disulfide bridge.lld:pubmed
pubmed-article:12238917pubmed:affiliationDepartment of Pharmaceutical and Toxicological Chemistry, University of Naples Federico II, I-80131 Naples, Italy.lld:pubmed
pubmed-article:12238917pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:12238917lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12238917lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12238917lld:pubmed